	Clustering of quantitative CT features identifies HCC subtypes with distinct prognosis and immune signatures. Eur Radiol Exp Wu S, Peng F, Huang J, Xu L, Zhang X, Bao Y, Chen Y. PMID: 42201507 [PubMed - indexed for MEDLINE]
	Risk Factors for Hepatocellular Carcinoma in Latino Populations in Texas: A Scoping Review. Int J Mol Sci Tuzino Kamia LY, Gonzalez E, Swanson CM, Gomez SL, Canales AM, Price RS. PMID: 42196623 [PubMed - indexed for MEDLINE]
	Regulatory T Cells in Hepatocellular Carcinoma: Spatial Niches, Biomarkers, and Clinical Implications. Int J Mol Sci Liapopoulos D, Sarantis P, Zogas G, Trifylli EM, Bousou TE, Kamitaki K, Anastasiou IA, Kokkali S, Mavromatis S, Koustas E, Elefsiniotis I, Biniari T, Karamouzis MV. PMID: 42196608 [PubMed - indexed for MEDLINE]
	CRISPR Screening in Hepatocellular Carcinoma: From Tumor Progression to Immune Evasion and Therapeutic Resistance. Int J Mol Sci Ma S, Li Y, Fei T. PMID: 42196223 [PubMed - indexed for MEDLINE]
	Comparison of Sevoflurane and Desflurane on Hepatocellular Carcinoma Recurrence After Living Donor Liver Transplantation: A Propensity Score-Matched Analysis. Medicina (Kaunas) Bae HJ, Kang SJ, Kim KS, Kwon HM, Jun IG, Song JG, Hwang GS. PMID: 42195128 [PubMed - indexed for MEDLINE]
	Early Recurrence of HCC Is Driven by Inflammation-Related HIF-1α Independent Angiogenesis Rather than Hypoxia-Induced Immune Escape. Biomolecules Siregar L, Gani RA, Lalisang TJM, Hasan I, Suhendro, Soejono H, Kresno SB, Siregar NC, Bestari MB. PMID: 42194070 [PubMed - indexed for MEDLINE]
	Deciphering Lipid Metabolic Landscape of Sorafenib-Treated Hepatocellular Carcinoma by Mass Spectrometry Imaging and Transcriptomics. Biomolecules Li D, Tuo Y, Sai L, Xu X, Peng F, Yan Z, Yang Q, Zhao H, Zhang R. PMID: 42194025 [PubMed - indexed for MEDLINE]
	Lenvatinib Combined with New FP Hepatic Arterial Infusion Chemotherapy for Unresectable Hepatocellular Carcinoma: Clinical Efficacy, Vascular Remodeling, and Implications for Immuno-Oncology-Systemic Combination Therapy. Curr Oncol Maruta S, Koshima Y, Debari Y, Sugihara C, Takahata G, Tamura R, Ohshima T, Ono Y, Morita Y, Chiba T, Ishida S, Imai H, Watanabe K, Chinzei R, Takahashi M, Ooka Y. PMID: 42187603 [PubMed - indexed for MEDLINE]
	Imaging Features and Clinical Outcomes of Ischemic Cholangiopathy After Drug-Eluting Bead Transarterial Chemoembolization for Hepatocellular Carcinoma: A Retrospective Single-Center Cohort Study and Literature Review. Curr Oncol , Popovi, De, Ur, Zaplotnik M, , Finderle S, . PMID: 42187571 [PubMed - indexed for MEDLINE]
	MRI-based clinicoradiologic model for identifying MT-HCC with distinct postoperative prognosis and potential association with postoperative TKI-ICI therapy. Front Immunol Li Y, Qin Z, Cheng J, Li X, Liu C, Li Q, Zhang H, Cai P, Chen F, Chen W, Li X. PMID: 42183283 [PubMed - indexed for MEDLINE]
	Research progress of tertiary lymphoid structure in hepatocellular carcinoma: from prognostic biomarkers to new strategies for immunotherapy. Front Immunol Yuan S, Luo X, Li S, Cao L, Chen X, Wang L, Liu Y, Li Z, Wu T, Fang H, Tong M. PMID: 42183255 [PubMed - indexed for MEDLINE]
	Disulfidptosis in hepatocellular carcinoma: molecular mechanisms, therapeutic potential, and exploratory insights into chronic liver diseases. Apoptosis Liu Y, Hu W, Mai J, Cheng Y. PMID: 42177709 [PubMed - indexed for MEDLINE]
	Breakthroughs in HBV-related HCC Therapy: The Unmatched Potential of Immune Checkpoint Inhibitors. Curr Treat Options Oncol Liu C, Chang L, Yan Y, Ji H, Ma J, Sun H, Wang L. PMID: 42176073 [PubMed - indexed for MEDLINE]
	Expression and prognostic value of cholesterol homeostasis genes in hepatocellular carcinoma: A cohort study based on TCGA. Medicine (Baltimore) Ding C, Huo J, Xu YQ, Zhang H, Gong Y, Hao D, Meng D. PMID: 42175500 [PubMed - indexed for MEDLINE]
	Multimodal Graph-Based Model for Discrete-Time Survival Prediction in Liver Cancer. Stud Health Technol Inform Akebli H, Della Mea V, Roitero K. PMID: 42174858 [PubMed - indexed for MEDLINE]
	Building an Ontology-Based Cohort of Liver Cancer Imaging Data for AI Development on the European Federated Platform EUCAIM. Stud Health Technol Inform Guedjali A, Mondet K, Beaufrere A, Gregory J, Mule S, Paradis V, Fournier L, Daniel C, El Ghosh M. PMID: 42174810 [PubMed - indexed for MEDLINE]
	Outcomes of Hepatocellular Carcinoma involving the Portal Vein Main Trunk and/or the Inferior Vena Cava: Experience From a Multidisciplinary Liver Cancer Clinic. Cancer Med Liu IC, Zaheer A, Hu C, Shubert C, Lafaro K, Burns WR, Burkhart R, He J, Philosophe B, Zorzi J, Griffith P, Strauss AT, Kim AK, Liddell R, Hong K, Georgiades C, Anders R, Oshima K, Hallab E, Narang A, Ho WJ, Yarchoan M, Baretti M, Meyer J. PMID: 42174390 [PubMed - indexed for MEDLINE]
	Pandemic-Related Disruptions and Hepatocellular Carcinoma Surveillance in Safety-Net Settings. JAMA Netw Open Wong RJ, Jones P, Niu B, Pinheiro P, Thamer M, Kshirsagar O, Zhang Y, Fass R, Prieto-Bello D, Quirk L, Therapondos G, Singal AG, Khalili M. PMID: 42172025 [PubMed - indexed for MEDLINE]
	Advancing Systemic Treatment beyond First Line for Advanced Hepatocellular Carcinoma. Curr Oncol Rep Wysocki PT, Chmiel P, Jassem J, Kraj L. PMID: 42171914 [PubMed - indexed for MEDLINE]
	Transcatheter CT Hepatic Arteriography versus Conventional CT Guidance for Percutaneous Microwave Ablation of Small Hepatocellular Carcinoma Tumors. Radiol Imaging Cancer Yu Q, Ahmed Z, Lim W, Hwang G, Zhang M, Kwak D, Liao C, Patel M, Liao CY, Pillai A, Fung J, Van Ha T, Funaki B, Ahmed O. PMID: 42171489 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 76230

Page 1 of 3812



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy